Ischaemic and bleeding risk in cancer patients undergoing PCI: another brick in the wall.
暂无分享,去创建一个
[1] Deepak L. Bhatt,et al. Percutaneous coronary intervention in patients with cancer and readmissions within 90 days for acute myocardial infarction and bleeding in the USA. , 2021, European heart journal.
[2] N. Lannin,et al. Factors Associated with Stroke Coding Quality: A Comparison of Registry and Administrative Data. , 2020, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.
[3] C. Cipolla,et al. Characteristics, Management, and Outcomes of Acute Coronary Syndrome Patients with Cancer , 2020, Journal of clinical medicine.
[4] M. Price,et al. Polymer-based or Polymer-free Stents in Patients at High Bleeding Risk. , 2020, The New England journal of medicine.
[5] L. Räber,et al. Ischemia and Bleeding in Cancer Patients Undergoing Percutaneous Coronary Intervention , 2019, JACC. CardioOncology.
[6] H. Jneid,et al. Acute Coronary Syndromes in Cancer Patients. , 2019, European heart journal.
[7] R. Souza,et al. Cancer-associated thrombosis: the when, how and why , 2019, European Respiratory Review.
[8] D. Fischman,et al. Percutaneous coronary intervention in cancer patients: a report of the prevalence and outcomes in the United States. , 2018, European heart journal.
[9] Takeshi Kimura,et al. Influence of a history of cancer on long-term cardiovascular outcomes after coronary stent implantation (an Observation from Coronary Revascularization Demonstrating Outcome Study-Kyoto Registry Cohort-2) , 2018, European heart journal. Quality of care & clinical outcomes.
[10] H. Kamel,et al. Risk of Arterial Thromboembolism in Patients With Cancer. , 2017, Journal of the American College of Cardiology.
[11] G. Lip,et al. 2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: The Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC). , 2016, European heart journal.
[12] C. Criscitiello,et al. Cardiotoxicity of anticancer treatments: Epidemiology, detection, and management , 2016, CA: a cancer journal for clinicians.
[13] A. Falanga,et al. Coagulation and cancer: biological and clinical aspects , 2013, Journal of thrombosis and haemostasis : JTH.
[14] J. Durand,et al. Treatment and Outcomes of Acute Coronary Syndrome in the Cancer Population , 2012, Clinical cardiology.
[15] T. Truelsen,et al. Validity of Stroke Diagnoses in a National Register of Patients , 2007, Neuroepidemiology.